Since an increase in sEng plasma levels in patients with CRC was found, we detected in situ Endoglin membrane expression by immunohistochemistry in tumoral versus non-tumoral tissue samples to correlate the sEng levels found in plasma. This evidence concerns the gene ENG and colorectal carcinoma.